These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 28281194)

  • 1. Development Considerations for Nanocrystal Drug Products.
    Chen ML; John M; Lee SL; Tyner KM
    AAPS J; 2017 May; 19(3):642-651. PubMed ID: 28281194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In silico predictions of gastrointestinal drug absorption in pharmaceutical product development: application of the mechanistic absorption model GI-Sim.
    Sjögren E; Westergren J; Grant I; Hanisch G; Lindfors L; Lennernäs H; Abrahamsson B; Tannergren C
    Eur J Pharm Sci; 2013 Jul; 49(4):679-98. PubMed ID: 23727464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of mucosal immune profile associated with Zileuton nanocrystal-formulated BCS-II drug upon oral administration in Sprague Dawley rats.
    Khare S; Jog R; Bright A; Burgess DJ; Chakder SK; Gokulan K
    Nanotoxicology; 2023 Dec; 17(10):583-603. PubMed ID: 38146991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Manufacturing classification system in the real world: factors influencing manufacturing process choices for filed commercial oral solid dosage formulations, case studies from industry and considerations for continuous processing.
    Leane M; Pitt K; Reynolds GK; Dawson N; Ziegler I; Szepes A; Crean AM; Dall Agnol R; The Manufacturing Classification System McS Working Group
    Pharm Dev Technol; 2018 Dec; 23(10):964-977. PubMed ID: 30320539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanocrystal Based Drug Delivery System: Conventional and Current Scenario.
    Thakkar S; Shah V; Misra M; Kalia K
    Recent Pat Nanotechnol; 2017 Jul; 11(2):130-145. PubMed ID: 27758683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanocrystal technologies in biomedical science: From the bench to the clinic.
    Pardhi E; Vasave R; Srivastava V; Yadav R; Mehra NK
    Drug Discov Today; 2024 Mar; 29(3):103913. PubMed ID: 38340952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanocrystals Technology for Improving Bioavailability of Poorly Soluble Drugs: A Mini-Review.
    Zhou Y; Du J; Wang L; Wang Y
    J Nanosci Nanotechnol; 2017 Jan; 17(1):18-28. PubMed ID: 29616786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanocrystals Technology for Pharmaceutical Science.
    Cheng Z; Lian Y; Kamal Z; Ma X; Chen J; Zhou X; Su J; Qiu M
    Curr Pharm Des; 2018; 24(21):2497-2507. PubMed ID: 29773056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanocrystals: industrially feasible multifunctional formulation technology for poorly soluble actives.
    Shegokar R; Müller RH
    Int J Pharm; 2010 Oct; 399(1-2):129-39. PubMed ID: 20674732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanocrystal for ocular drug delivery: hope or hype.
    Sharma OP; Patel V; Mehta T
    Drug Deliv Transl Res; 2016 Aug; 6(4):399-413. PubMed ID: 27165145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amorphous solid dispersions and nanocrystal technologies for poorly water-soluble drug delivery - An update.
    Jermain SV; Brough C; Williams RO
    Int J Pharm; 2018 Jan; 535(1-2):379-392. PubMed ID: 29128423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent Advances in Co-processed APIs and Proposals for Enabling Commercialization of These Transformative Technologies.
    Schenck L; Erdemir D; Saunders Gorka L; Merritt JM; Marziano I; Ho R; Lee M; Bullard J; Boukerche M; Ferguson S; Florence AJ; Khan SA; Sun CC
    Mol Pharm; 2020 Jul; 17(7):2232-2244. PubMed ID: 32392068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanosizing: a formulation approach for poorly-water-soluble compounds.
    Merisko-Liversidge E; Liversidge GG; Cooper ER
    Eur J Pharm Sci; 2003 Feb; 18(2):113-20. PubMed ID: 12594003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of drug nanocrystal technologies on oral drug delivery of poorly soluble drugs.
    Gao L; Liu G; Ma J; Wang X; Zhou L; Li X; Wang F
    Pharm Res; 2013 Feb; 30(2):307-24. PubMed ID: 23073665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Engineered nanocrystal technology: in-vivo fate, targeting and applications in drug delivery.
    Pawar VK; Singh Y; Meher JG; Gupta S; Chourasia MK
    J Control Release; 2014 Jun; 183():51-66. PubMed ID: 24667572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent developments in the use of nanocrystals to improve bioavailability of APIs.
    Ding Y; Zhao T; Fang J; Song J; Dong H; Liu J; Li S; Zhao M
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2024; 16(2):e1958. PubMed ID: 38629192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug nanocrystals in the commercial pharmaceutical development process.
    Möschwitzer JP
    Int J Pharm; 2013 Aug; 453(1):142-56. PubMed ID: 23000841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brinzolamide nanocrystal formulations for ophthalmic delivery: reduction of elevated intraocular pressure in vivo.
    Tuomela A; Liu P; Puranen J; Rönkkö S; Laaksonen T; Kalesnykas G; Oksala O; Ilkka J; Laru J; Järvinen K; Hirvonen J; Peltonen L
    Int J Pharm; 2014 Jun; 467(1-2):34-41. PubMed ID: 24680962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanosizing techniques for improving bioavailability of drugs.
    Al-Kassas R; Bansal M; Shaw J
    J Control Release; 2017 Aug; 260():202-212. PubMed ID: 28603030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Challenges and solutions for the delivery of biotech drugs--a review of drug nanocrystal technology and lipid nanoparticles.
    Muller RH; Keck CM
    J Biotechnol; 2004 Sep; 113(1-3):151-70. PubMed ID: 15380654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.